Adrienne Asch (1999), ‘Prenatal Diagnosis and Selective Abortion: A Challenge to Practice and Policy’, American Journal o f Public Health, 89, pp. 1649-57

Abortion ◽  
2017 ◽  
pp. 485-494
The Lancet ◽  
1969 ◽  
Vol 294 (7625) ◽  
pp. 845
Author(s):  
L.L. De Veber

1999 ◽  
Vol 7 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Yury Verlinsky ◽  
Anver Kuliev

Preimplantation diagnosis of inherited and chromosomal diseases allows couples at risk of conceiving a genetically abnormal fetus to avoid the birth of an affected child without the need for a prenatal diagnosis and selective abortion of an affected fetus. For some couples this may be the only option, because they cannot accept termination of pregnancy as a measure of avoiding the birth of an affected child. Even for those who accept prenatal diagnosis, repeated termination of pregnancy forces them to look for other options to control the outcome of their pregnancies from the very outset. This may be achieved by genetic analysis of oocytes or cleaving embryos, which opens a new prospect for ‘prepregnancy’ genetic diagnosis. As will be shown, such an approach will also be a useful addition to assisted reproduction technologies, at least for in vitro fertilization (IVF) patients of advanced maternal age.


OBM Genetics ◽  
2021 ◽  
Vol 05 (03) ◽  
pp. 1-1
Author(s):  
Robert Resta ◽  

The goals of prenatal testing remain controversial and reflect competing interests of public health, patient rights, disability activists, scholars, feminist critics, commercial laboratories, judiciary/legislative trends, and medical science. This paper reviews and critiques the most common justifications of prenatal testing for fetal aneuploidy that have been put forth over the half century of its existence: reducing the medical and economic burden to society of genetic disease through selective abortion, allowing parents to avoid raising a child with disabilities, preventing the suffering associated with chromosomal and genetic disorders, emotional reassurance about the health of the baby, and medical and emotional preparation for the birth of a baby with a disability. Each of these goals has problematic aspects, as do some of the criticisms of these goals. The most striking shortcoming of the justifications for prenatal testing is a dearth of research about potential medical, psychological, or adaptational benefits of prenatal testing, especially for aneuploidy, for babies and families, beyond the option of pregnancy termination.


The Lancet ◽  
1969 ◽  
Vol 294 (7629) ◽  
pp. 1067
Author(s):  
LyttI. Gardner

Author(s):  
Alessandra Carnevale ◽  
Rub�n Lisker ◽  
Antonio R. Villa ◽  
Salvador Armendares

Sign in / Sign up

Export Citation Format

Share Document